 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- | flanvotumab (LY3012215) / Eli Lilly
Trial completion: An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma (clinicaltrials.gov) - Sep 25, 2012
P1, N=27, Completed, Sponsor: ImClone LLC
Active, not recruiting --> Completed
- flanvotumab (LY3012215) / Eli Lilly
Enrollment change: An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma (clinicaltrials.gov) - Apr 5, 2012
P1, N=27, Completed, Sponsor: ImClone LLC
Active, not recruiting --> Completed N=45 --> 27